Evoke Pharma, Inc.
(NASDAQ : EVOK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 19.32%82.970.0%$464.09m
ICLRICON plc 0.37%244.172.8%$349.76m
VRXValeant Pharmaceuticals International, Inc. 1.27%29.6214.1%$174.29m
HZNPHorizon Therapeutics Plc -0.94%99.085.5%$111.71m
JAZZJazz Pharmaceuticals Plc 0.64%170.602.2%$84.73m
CTLTCatalent, Inc. 0.54%120.462.1%$77.15m
PRGOPerrigo Co. Plc 1.03%48.536.9%$49.39m
ENDPEndo International Plc -0.39%5.048.6%$45.85m
BHCBausch Health Cos., Inc. 1.27%29.620.0%$43.06m
ARGXargenx SE 1.58%309.250.0%$40.66m
UTHRUnited Therapeutics Corp. -0.47%181.0714.0%$39.17m
SAGESAGE Therapeutics, Inc. 1.02%44.187.6%$32.64m
NTECIntec Pharma Ltd. -1.65%11.100.0%$31.03m
IRWDIronwood Pharmaceuticals, Inc. 0.60%13.359.6%$25.47m
AXSMAxsome Therapeutics, Inc. 4.24%50.651.9%$17.99m

Company Profile

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.